Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Complement Ther Med. 2020 Feb 15;49:102348. doi: 10.1016/j.ctim.2020.102348

Table 4.

Estimates of linear mixed model for changes in EDR from 12-months pre- to post-treatment

Estimate SE p-value
Intercept 0.62 0.07 <.001
Genotype (HbSS + HbSB0) 0.10 0.04 <.05
Number of Therapy Sessions −0.01 0.01 <.01
Therapy Attendance Group
 Established Care in CBT −0.05 0.04 ns
 Early Termination 0.19 0.10 ns
Time −0.08 0.04 <.05

Note: Scores are estimated assuming HbSS/HbSB0 genotype